These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 15781008)

  • 21. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 22. [Long-term effect of amiodarone therapy following myocardial infarct in patients with complex ventricular arrhythmias].
    Kiowski W; Brunner H; Pfisterer M; Burckhardt D; Burkart F
    Schweiz Med Wochenschr; 1993 Mar; 123(12):533-6. PubMed ID: 8475360
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Anti-arrhythmia therapy after myocardial infarct: preliminary results of EMIAT and CAMIAT studies].
    Kuck KH
    Z Kardiol; 1996; 85 Suppl 6():107-13. PubMed ID: 9064953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical efficacy of amiodarone.
    Nolan PE; Nappi J; Pollak PT
    Pharmacotherapy; 1998; 18(6 Pt 2):127S-137S. PubMed ID: 9855345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictive value of microvolt T-wave alternans for sudden cardiac death in patients with preserved cardiac function after acute myocardial infarction: results of a collaborative cohort study.
    Ikeda T; Yoshino H; Sugi K; Tanno K; Shimizu H; Watanabe J; Kasamaki Y; Yoshida A; Kato T
    J Am Coll Cardiol; 2006 Dec; 48(11):2268-74. PubMed ID: 17161258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicentre randomized trial of sotalol vs amiodarone for chronic malignant ventricular tachyarrhythmias. Amiodarone vs Sotalol Study Group.
    Eur Heart J; 1989 Aug; 10(8):685-94. PubMed ID: 2676535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of cardiac autonomic regulation and ventricular repolarization after off-pump coronary artery bypass grafting.
    Kalisnik JM; Avbelj V; Trobec R; Ivaskovic D; Vidmar G; Troise G; Gersak B
    Heart Surg Forum; 2006; 9(3):E661-7. PubMed ID: 16753938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic utility of microvolt T-wave alternans in risk stratification of patients with ischemic cardiomyopathy.
    Chow T; Kereiakes DJ; Bartone C; Booth T; Schloss EJ; Waller T; Chung ES; Menon S; Nallamothu BK; Chan PS
    J Am Coll Cardiol; 2006 May; 47(9):1820-7. PubMed ID: 16682307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictive significance for sudden death of microvolt-level T wave alternans in New York Heart Association class II congestive heart failure patients: a prospective study.
    Baravelli M; Salerno-Uriarte D; Guzzetti D; Rossi MC; Zoli L; Forzani T; Salerno-Uriarte JA
    Int J Cardiol; 2005 Oct; 105(1):53-7. PubMed ID: 16207545
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amiodarone versus Implantable Defibrillator (AMIOVIRT): background, rationale, design, methods, results and implications.
    Wijetunga M; Strickberger SA;
    Card Electrophysiol Rev; 2003 Dec; 7(4):452-6. PubMed ID: 15071274
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].
    Funck-Brentano C
    Rev Prat; 1992 Nov; 42(17):2175-8. PubMed ID: 1290040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Should survivors of myocardial infarction with low ejection fraction be routinely referred to arrhythmia specialists?
    Stevenson WG; Ridker PM
    JAMA; 1996 Aug; 276(6):481-5. PubMed ID: 8691557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arrhythmic risk stratification of post-myocardial infarction patients.
    Naccarella F; Lepera G; Rolli A
    Curr Opin Cardiol; 2000 Jan; 15(1):1-6. PubMed ID: 10666655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials.
    Yap YG; Duong T; Bland JM; Malik M; Torp-Pederson C; Køber L; Connolly SJ; Gallagher MM; Camm AJ
    J Hypertens; 2007 Feb; 25(2):307-13. PubMed ID: 17211237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of thromboembolism in heart failure: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Freudenberger RS; Hellkamp AS; Halperin JL; Poole J; Anderson J; Johnson G; Mark DB; Lee KL; Bardy GH;
    Circulation; 2007 May; 115(20):2637-41. PubMed ID: 17485579
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of post acute myocardial infarction patients with potential benefit from prophylactic treatment with amiodarone. A substudy of EMIAT (the European Myocardial Infarct Amiodarone Trial).
    Janse MJ; Malik M; Camm AJ; Julian DG; Frangin GA; Schwartz PJ
    Eur Heart J; 1998 Jan; 19(1):85-95. PubMed ID: 9503180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trimetazidine potentiates the effects of exercise training in patients with ischemic cardiomyopathy referred for cardiac rehabilitation.
    Belardinelli R; Lacalaprice F; Faccenda E; Volpe L
    Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):533-40. PubMed ID: 18797405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of concomitant antiarrhythmic therapy on survival in patients with implantable cardioverter defibrillators.
    Ho AT; Pai SM; Timothy P; Pai RG
    Pacing Clin Electrophysiol; 2005 Jul; 28(7):647-53. PubMed ID: 16008799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bedside risk stratification after acute myocardial infarction: prospective evaluation of the use of heart rate and left ventricular function.
    Mauss O; Klingenheben T; Ptaszynski P; Hohnloser SH
    J Electrocardiol; 2005 Apr; 38(2):106-12. PubMed ID: 15892019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.